“We found that lymphedema deregulates at least six molecular pathways and that hydroxytyrosol , a compound with antioxidant activity, can improve endothelial dysfunction, hemostatic and lipid profiles, and decrease oxidative stress and inflammation through inhibition of leukotriene B4 activity.”